Сообщение №69013599

Pfizer/BioNTech said Monday that it was working with the government's Operation Warp Speed (OWS) to conduct an immunization pilot program in Rhode Island, Texas, New Mexico, and Tennessee that will help refine delivery and deployment plans.

United Kingdom: In July, Pfizer/BioNTech said an agreement was reached with the U.K. to supply 30 million doses of the BNT162 mRNA-based candidate. That appears to have since increased to 40 million doses, according to a U.K. government release.

Japan: On July 31, the companies said 120 million doses of the BNT162 mRNA-based vaccine candidate would be supplied to Japan beginning in 2021. As with most deals, the agreement was subject to its clinical success and regulatory approvals.

Canada: Pfizer/BioNTech said in August an agreement with the government of Canada had been reached, but did not disclose financial or dosage information.

European uniоn: On November 11, the European Commission said it had approved a contract with BioNTech and Pfizer settled on an initial purchase of 200 million doses on behalf of all the E.U. States, with an option to request up to a 100 million more.

Australia: Prime Minister Scott Morrison announced in a press release on November 5 that Australia would be supplied with 10 million vaccine doses from Pfizer/BioNTech.